ReACT for Functional Seizures
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two therapy approaches to help young people with functional seizures, which resemble epileptic seizures but lack a neurological cause. Participants will receive either Retraining and Control Therapy (ReACT), which focuses on managing seizures through a therapist-guided plan, or the CATCH-IT program (Competent Adulthood Transition with Cognitive Behavioral, Humanistic, and Interpersonal Training), which uses online cognitive behavioral training with family involvement. The trial aims to assess the feasibility of a larger study to determine which treatment is more effective. It seeks participants aged 11-18 who have functional seizures and internet access for telehealth sessions.
As an unphased trial, this study offers participants the chance to contribute to pioneering research that could shape future treatment options for functional seizures.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does exclude participants who are currently in other therapy, which might suggest some restrictions on concurrent treatments.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both the ReACT and CATCH-IT treatments are generally easy for patients to handle. ReACT improves symptoms in children and teens with functional seizures, with no significant reports of serious side effects, suggesting it is a safe option for many patients.
CATCH-IT, an online therapy, has been studied for its effectiveness in mental health issues like depression. These studies also report it as safe, with no major negative effects. Participants usually manage it well, making it a reliable choice.
Overall, various studies have demonstrated that both treatments are safe and well-tolerated, which is encouraging for those considering joining this trial.12345Why are researchers excited about this trial?
Researchers are excited about the ReACT and CATCH-IT interventions for functional seizures because they take a unique approach compared to traditional treatments, which often involve medication. ReACT stands out by providing a structured therapy plan with personalized sessions that focus on retraining the brain to manage seizures differently, using a hands-on approach with a therapist. Meanwhile, CATCH-IT offers an innovative web-based program that incorporates cognitive behavioral therapy (CBT) modules, engaging both the parent and child in the process. This dual approach not only aims to address the psychological aspects of functional seizures but also empowers participants with practical skills to manage their symptoms effectively.
What evidence suggests that this trial's treatments could be effective for functional seizures?
Research has shown that Retraining and Control Therapy (ReACT), one of the treatments in this trial, may help treat functional seizures in children. Specifically, studies found that children who received ReACT experienced fewer seizures. This therapy teaches them new ways to think about and respond to their symptoms, which appears effective.
Regarding the CATCH-IT treatment, another option in this trial, research suggests it can support mental health through online cognitive-behavioral strategies. While it primarily aims to prevent depression, it might also help manage functional seizures by enhancing emotional well-being and coping skills. Both treatments are under study in this trial for their potential to aid young people with functional seizures.14678Are You a Good Fit for This Trial?
This trial is for boys and girls aged 11-18 with a diagnosis of functional seizures. They must have internet access for telehealth sessions. Those with comorbid epilepsy, less than four seizures per month, severe intellectual disability, involvement in other therapies or severe mental illness are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants and their family member/caregiver complete questionnaires and receive a functional seizure diary
Treatment
Participants undergo 12 therapy sessions of either ReACT or CATCH-IT, with the first session in-person and the rest via telehealth
Follow-up
Participants are monitored for safety and effectiveness after treatment with follow-up visits
Long-term Follow-up
Participants have additional follow-up visits to assess long-term outcomes
What Are the Treatments Tested in This Trial?
Interventions
- CATCH-IT
- ReACT
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Yale University
Collaborator
Baylor College of Medicine
Collaborator